News

Remembering Professor Chris Redman: a visionary behind the Dawes-Redman System

18th September 2024

All News

Since 1980, Oxford University Innovation (OUI) has overseen the licensing and commercialisation of the Dawes-Redman Cardiotocography (CTG) analysis system. This technology, used worldwide to monitor fetal health during pregnancy, is considered one of the University of Oxford’s most successful clinical advances.

“The future of fuel lies in e-fuels, which will be pivotal to the global energy transition.”

6th September 2024

All News | Spinouts & Startups

Oxford University Innovation celebrates the launch of OXCCU's demonstration plant

StEP Ignite 2024: OUI programme supports students building start-ups

15th August 2024

All News | Spinouts & Startups | Startup Incubator

The team behind MariTest, a non-invasive test for malaria, are the winners of this year’s Student Entrepreneurship Programme

Mental health programmes designed to support social anxiety and PTSD.

New therapies developed by Oxford experts offer online support for anxiety and post-traumatic stress disorders 

31st July 2024

All News

Four internet-based therapies developed by experts at the University of Oxford’s Department of Experimental Psychology and Department of Psychiatry are proving helpful for patients with social anxiety disorder and post-traumatic stress disorders and for children with anxiety disorders.

MatchBio spinout set to revolutionise immunotherapy

29th July 2024

All News | Spinouts & Startups

A new company, MatchBio, founded by Professors Omer Dushek and Anton van der Merwe from the Dunn School of Pathology, is set to revolutionise immunotherapy by enhancing CAR T therapy.

Apollo Therapeutics and the University of Oxford enter into drug discovery and development collaboration

22nd July 2024

All News

Apollo Therapeutics will inject capital and expertise into pipeline of potentially lifesaving medicines through an agreement with the University of Oxford. The collaboration highlights a shared strategic intent to develop new therapeutics based on breakthroughs in biology and basic medical research at the University of Oxford.

Image from Oxford Semantic Technologies – an Oxford University spinout specialising in knowledge graph and reasoning technology – acquired by Samsung Electronics News Article

Oxford Semantic Technologies – an Oxford University spinout specialising in knowledge graph and reasoning technology – acquired by Samsung Electronics

18th July 2024

All News | Spinouts & Startups

An Oxford University spinout which supports accurate AI applications using Knowledge & Reasoning has been bought by Samsung Electronics.

Oxford Innovation Society (OIS)

18th July 2024

All News | Spinouts & Startups

Oxford University Innovation recently hosted two landmark events that brought together global investors, leading industry experts and innovative spinouts, showcasing the vibrant ecosystem of collaboration and cutting-edge technology at Oxford.

Tech transfer partnership between universities creates company to transform care for millions of women

18th July 2024

All News | Financial News | Partners | Spinouts & Startups | Technology News

Amber Therapeutics successfully closed Series A funding of $100 million (£80 million) from leading healthcare and technology investors in the US and UK.

Enhancing clinical trials: The vital role of Clinical Outcome Assessments

17th July 2024

All News | Clinical Outcomes

Discover why Clinical Outcome Assessments (COAs) are vital in clinical trials for measuring patient outcomes and ensuring reliable data for regulatory approval and improved patient care.

News

Ready to get in touch?